Comparative Pharmacology
Head-to-head clinical analysis: CYCLOCORT versus FLUTEX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CYCLOCORT versus FLUTEX.
CYCLOCORT vs FLUTEX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Topical corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive actions. Suppresses cytokine production, inhibits phospholipase A2, and reduces prostaglandin synthesis.
Flutamide is a nonsteroidal antiandrogen that competitively inhibits the binding of dihydrotestosterone (DHT) to androgen receptors in target tissues, thereby blocking the androgenic effects.
Apply a thin film topically to affected area twice daily (morning and evening). Not for ophthalmic use.
50 mg orally once daily
None Documented
None Documented
3.5 hours (terminal); clinical effect duration longer due to tissue binding.
Terminal elimination half-life: 24–36 hours, permitting once-daily dosing in chronic therapy
Primarily hepatic metabolism; inactive metabolites excreted renally (<1% unchanged) and in feces (biliary).
Renal: ~70% (50% unchanged, 20% as metabolites); Biliary/fecal: ~30%
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid